P1821 for Dysarthria

MQ
Overseen ByMatthew Quitto II
Age: Any Age
Sex: Any
Trial Phase: Academic
Sponsor: Dream Video LLC
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The P1821 initiative constitutes an innovative intervention specifically engineered to enhance tongue muscular strength and endurance. The primary objective of this research study is to ascertain whether the integration of a proactive tongue strengthening exercise regimen, utilizing a Non-Significant Risk (NSR) Device, contributes to an observable improvement in speech fluency.

Are You a Good Fit for This Trial?

Inclusion Criteria

Willing and able to follow the requirements of the protocol
Can read and write

Exclusion Criteria

I have been treated by a speech therapist for swallowing or speech problems not caused by head or neck cancer.
Medical instability, restlessness, or other factors that would compromise data acquisition

What Are the Treatments Tested in This Trial?

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: P1821 #1Experimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Dream Video LLC

Lead Sponsor

Dream Holdings Research

Collaborator